Tomas Yeo

2.1k total citations
17 papers, 424 citations indexed

About

Tomas Yeo is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Tomas Yeo has authored 17 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 7 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Tomas Yeo's work include Malaria Research and Control (13 papers), HIV/AIDS drug development and treatment (7 papers) and Computational Drug Discovery Methods (3 papers). Tomas Yeo is often cited by papers focused on Malaria Research and Control (13 papers), HIV/AIDS drug development and treatment (7 papers) and Computational Drug Discovery Methods (3 papers). Tomas Yeo collaborates with scholars based in United States, United Kingdom and Switzerland. Tomas Yeo's co-authors include David A. Fidock, Sachel Mok, Satish K. Dhingra, Leila S. Ross, Rick M. Fairhurst, Frédéric Ariey, Didier Ménard, Shannon Takala‐Harrison, Krittikorn Kümpornsin and Kathryn J. Wicht and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Tomas Yeo

16 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Yeo United States 7 374 151 83 64 60 17 424
Christopher L. Peatey Australia 13 451 1.2× 103 0.7× 56 0.7× 83 1.3× 54 0.9× 16 517
Mynthia Cabrera United States 14 413 1.1× 136 0.9× 77 0.9× 80 1.3× 104 1.7× 17 568
Silvana Sekuloski Australia 10 440 1.2× 94 0.6× 104 1.3× 78 1.2× 59 1.0× 11 510
Tuo Yang Australia 7 364 1.0× 138 0.9× 70 0.8× 120 1.9× 63 1.1× 8 467
Naoyuki Fukuda Japan 4 381 1.0× 132 0.9× 63 0.8× 89 1.4× 57 0.9× 9 463
Mie Ikeda Japan 4 395 1.1× 138 0.9× 57 0.7× 84 1.3× 61 1.0× 5 465
Krittikorn Kümpornsin Thailand 10 292 0.8× 118 0.8× 76 0.9× 54 0.8× 56 0.9× 15 343
Betty Balikagala Japan 7 490 1.3× 154 1.0× 62 0.7× 121 1.9× 76 1.3× 14 590
Alassane Mbengue United States 6 429 1.1× 176 1.2× 72 0.9× 142 2.2× 48 0.8× 13 561
Patrick K. Tumwebaze Uganda 14 551 1.5× 231 1.5× 68 0.8× 54 0.8× 99 1.6× 27 642

Countries citing papers authored by Tomas Yeo

Since Specialization
Citations

This map shows the geographic impact of Tomas Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Yeo more than expected).

Fields of papers citing papers by Tomas Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Yeo. The network helps show where Tomas Yeo may publish in the future.

Co-authorship network of co-authors of Tomas Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Yeo. A scholar is included among the top collaborators of Tomas Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Yeo. Tomas Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Padalino, Gilda, John Okombo, Tomas Yeo, et al.. (2025). Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activity. PLoS Pathogens. 21(2). e1012216–e1012216.
2.
Yeo, Tomas, et al.. (2024). Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost. The Journal of Infectious Diseases. 231(5). e976–e985. 2 indexed citations
3.
Bennett, John M., Stephanie Kabeche, Daniel Abegg, et al.. (2024). Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targets. Cell chemical biology. 31(9). 1714–1728.e10. 2 indexed citations
4.
5.
Bennett, John M., Kurt E. Ward, Ryan K. Muir, et al.. (2023). Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum. ACS Infectious Diseases. 9(10). 2036–2047. 5 indexed citations
6.
Dhingra, Satish K., Jennifer L. Small-Saunders, Gabriel W. Rangel, et al.. (2023). Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology. mBio. 15(1). e0183223–e0183223. 6 indexed citations
7.
Okombo, John, Sachel Mok, Tomas Yeo, et al.. (2022). Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages. PLoS Pathogens. 18(10). e1010926–e1010926. 12 indexed citations
8.
Laleu, Benoı̂t, Kelly Rubiano, Tomas Yeo, et al.. (2022). Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2. ChemMedChem. 17(22). e202200393–e202200393. 7 indexed citations
9.
Mok, Sachel, Barbara H. Stokes, Nina F. Gnädig, et al.. (2021). Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival. Nature Communications. 12(1). 530–530. 89 indexed citations
10.
Held, Jana, Bjoern B. Burckhardt, Kelly Rubiano, et al.. (2021). 3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparum. Journal of Medicinal Chemistry. 64(6). 3035–3047. 6 indexed citations
11.
Dhingra, Satish K., Stanislaw J. Gabryszewski, Jennifer L. Small-Saunders, et al.. (2019). Global Spread of Mutant PfCRT and Its Pleiotropic Impact on Plasmodium falciparum Multidrug Resistance and Fitness. mBio. 10(2). 33 indexed citations
12.
Ross, Leila S., Satish K. Dhingra, Sachel Mok, et al.. (2018). Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nature Communications. 9(1). 3314–3314. 157 indexed citations
13.
Barber, Bridget E., Matthew J. Grigg, Kim A. Piera, et al.. (2017). ANTI-PHOSPHATIDYLSERINE IGM AND IGG ANTIBODIES ARE INCREASED IN FALCIPARUM AND VIVAX MALARIA AND CORRELATE WITH ANAEMIA. American Journal of Tropical Medicine and Hygiene. 97. 81–81. 1 indexed citations
14.
Dhingra, Satish K., Jill M. Combrinck, Tomas Yeo, et al.. (2017). A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug Piperaquine. mBio. 8(3). 96 indexed citations
15.
Grigg, Matthew J., Timothy William, Christopher J. Drakeley, et al.. (2015). FACTORS THAT ARE ASSOCIATED WITH THE RISK OF ACQUIRING PLASMODIUM KNOWLESI MALARIA IN SABAH, MALAYSIA: A CASE-CONTROL STUDY. American Journal of Tropical Medicine and Hygiene. 93. 84–85. 1 indexed citations
16.
Yeo, Tomas, Daniel A. Lampah, Enny Kenangalem, et al.. (2006). L-arginine infusion increases no production and reverses endothelial dysfunction in adults with moderately severe falciparum malaria in Papua, Indonesia. American Journal of Tropical Medicine and Hygiene. 75. 98–99. 4 indexed citations
17.
Yeo, Tomas, et al.. (1997). Rupture spontanée de rate au cours d'un paludisme à Plasmodium falciparum chez un sujet immun. 16(4). 176–178. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher L. Peatey Breakdown of academic impact, for papers by Mynthia Cabrera Breakdown of academic impact, for papers by Silvana Sekuloski Breakdown of academic impact, for papers by Tuo Yang Breakdown of academic impact, for papers by Naoyuki Fukuda Breakdown of academic impact, for papers by Mie Ikeda Breakdown of academic impact, for papers by Krittikorn Kümpornsin Breakdown of academic impact, for papers by Betty Balikagala Breakdown of academic impact, for papers by Alassane Mbengue Breakdown of academic impact, for papers by Patrick K. Tumwebaze
Rankless by CCL
2026